Altavant Sciences Advances Rodatristat Ethyl into Phase 2b Clinical Trial for Pulmonary Arterial Hypertension

NEXT STORY
Predictmedix announces technology deployment at Long Term Care residence in Edmonton, in partnership with Optima Living
PREV STORY
Agenus Corporate Update and First Quarter 2021 Financial Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus to Participate in William Blair’s Biotech Focus Conference 2021

author_avatar
NASDAQ Market News

Tiziana Life Sciences plc Change to ADS Ratio – Updated

author_avatar
NASDAQ Market News

Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals

author_avatar
NASDAQ Market News